Collagen may worsen Type 2 diabetes, IIT-Bombay study finds
In Type 2 diabetes, the pancreas produces both insulin and amylin. While insulin helps control blood sugar, excess amylin can misfold and form sticky clumps that damage the insulin-producing β-cells. The study found that in diabetic tissue, collagen I acts like a scaffold that speeds up amylin clumping, making it more toxic and harder for the body to clear.
The team used advanced lab techniques -- including surface plasmon resonance (to measure how tightly amylin sticks to collagen), atomic force microscopy (to study the force between molecules), thioflavin T fluorescence (to track clump formation), and NMR spectroscopy (to identify interacting regions) -- to show how collagen I accelerates amylin aggregation. Computer simulations and studies on diabetic mice and human tissue further confirmed the link.
Tests on lab-grown β-cells showed that when amylin and collagen were both present, the cells experienced more stress, higher death rates, and reduced insulin output.
The researchers say this highlights the importance of the environment around cells, not just what happens inside them. Targeting the interaction between amylin and collagen could lead to more effective treatments. The team is now developing models using cryo-electron microscopy and exploring ways to support pancreas repair using 3D scaffolds.
The study was funded by the Wadhwani Research Centre for Bioengineering, IIT Bombay and national research bodies including the Department of Biotechnology.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
26 minutes ago
- News18
Is Your Own Collagen Secretly Fueling Diabetes In You? IIT Study Uncovers Startling New Link
Last Updated: Scientists at IIT Bombay have found collagen protein helps form harmful hormone clumps in the pancreas, advancing understanding and opening doors to new diabetes treatments Diabetes is increasingly becoming a global health concern, with experts warning it may reach epidemic proportions in the coming decades. The disease primarily manifests in two forms: Type 1, an autoimmune condition with genetic links, and Type 2, whose precise causes remain largely unknown. In a groundbreaking study, researchers at IIT Bombay have uncovered a surprising connection between collagen, the body's most abundant structural protein, and the progression of Type 2 diabetes. Collagen appears to promote the accumulation of a hormone called amylin within the pancreas, impairing its function by reducing insulin production and thereby elevating blood sugar levels. The study, published in the Journal of the American Chemical Society, explains that alongside insulin, the body produces amylin to regulate blood sugar after meals. However, abnormal amylin can clump together as amyloid aggregates, damaging pancreatic beta cells and worsening diabetes. Professor Shamik Sen and his team revealed that fibrillar collagen 1 encourages the formation of these harmful clumps, increasing the risk of Type 2 diabetes. This new insight highlights the crucial role of structural proteins in diabetes development, beyond just blood sugar levels. These findings could lead to innovative treatments aimed at restoring pancreatic health by managing collagen and amylin levels, offering fresh hope to millions affected by Type 2 diabetes.
NDTV
2 hours ago
- NDTV
Muscles, Microbes, And Microgravity: India's First Biology Experiments In Space
New Delhi: India has taken its first bold steps into space biology with a series of pioneering experiments aboard the International Space Station (ISS), as part of the Axiom-4 mission-referred to by some as Mission Akash Ganga. These experiments, conducted by Group Captain Shubhanshu Shukla, mark a significant milestone in India's scientific and technological journey, exploring how biological systems behave in microgravity and radiation-rich environments. At the heart of this initiative is the Department of Biotechnology (DBT), under the leadership of Dr Rajesh Gokhale, Secretary of DBT. In an exclusive conversation with NDTV, Dr Gokhale described the mission as a "floating lab in space" that will help India understand biological adaptability in ways never tested before. The experiments are designed to explore fundamental questions about human health, sustainability, and bio-manufacturing in space. Muscle Stem Cell Regeneration In Microgravity One of the flagship experiments led by DBT focuses on skeletal muscle stem cells. Conducted by the Institute for Stem Cell Science and Regenerative Medicine (InStem) in Bengaluru, this study investigates how microgravity affects the regeneration of muscle tissue. In space, the absence of gravitational force leads to muscle and bone mass reduction, a phenomenon well-documented in astronauts. Dr Gokhale explained that the experiment will compare muscle stem cell behaviour in space with those grown under Earth conditions. The goal is to understand whether the regenerative capacity of these cells is compromised in microgravity. This research could have far-reaching implications - not only for astronaut health during long-duration missions but also for treating age-related muscle degeneration and diseases like muscular dystrophy on Earth. The experiment explores the role of mitochondria - the powerhouse of the cell - in maintaining muscle health. Mitochondrial dysfunction is a known contributor to muscle loss. DBT scientists are testing two compounds: dihydrofolate and a thiol-containing amino acid, both known to enhance mitochondrial function. By supplementing these chemicals in space-grown muscle cells, researchers aim to determine whether mitochondrial regeneration can be achieved in microgravity. If successful, this could lead to new therapeutic strategies for muscle recovery in space and on Earth, particularly for conditions like sarcopenia and cachexia. Edible Microalgae Cultivation One DBT-led experiment involves growing edible microalgae in space. Conducted by the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Delhi, this study examines how three species of microalgae adapt to space conditions. These algae are photosynthetic organisms that absorb carbon dioxide and release oxygen - making them ideal candidates for life support systems in space. Dr Gokhale emphasised the dual benefits of this experiment: oxygen generation and food production. Microalgae could serve as bio-regenerators in future missions like Gaganyaan, replacing traditional chemical-based systems like zeolites. Their ability to grow continuously and be consumed makes them a sustainable solution for long-term space habitation. Cyanobacteria For Nutrient Recycling Another innovative experiment focuses on cyanobacteria, known for their ability to recycle nutrients. Human urine, rich in urea and nitrogen, presents a challenge in closed-loop space environments. This study investigates how cyanobacteria assimilate nitrogen from both organic (urea) and inorganic (nitrate) sources. The aim is to convert waste into usable resources-a concept Dr Gokhale described as "waste to wealth in space". Understanding how these bacteria function in microgravity could lead to efficient nutrient recycling systems for future space stations and planetary habitats. Seed Sprouting And Crop Growth India is also conducting experiments on seed sprouting, involving crops like fenugreek (methi) and moong or green gram. These seeds are being grown in space to observe changes in growth patterns and microbial interactions. Although the sprouted seeds will not be consumed by Mr Shukla, they will be returned to Earth for detailed analysis. This experiment is part of a broader effort to understand how Indian crop varieties respond to space conditions. It could pave the way for space farming and food security in extra-terrestrial environments. Eye Function And Screen Exposure While not directly under DBT, another experiment examines how prolonged exposure to screens affects eye function in space. Vision problems have been reported among astronauts, and this study aims to understand the physiological changes that occur in microgravity. It adds a critical dimension to astronaut health research. Water Bears (Tardigrades) Reproduction A particularly intriguing experiment involves tardigrades, microscopic organisms known for their resilience. Researchers are studying their reproductive cycle in space, specifically whether they can lay and hatch eggs under microgravity conditions. This could offer insights into how complex biological processes like reproduction are affected by space environments. Seeds For Genetic Analysis India is also sending seeds of various crop varieties to space, not for growth but for genetic analysis upon return. This experiment, though previously conducted by other nations, carries an Indian signature and aims to understand how space exposure affects genetic traits. Implications For Bio-Manufacturing And Policy These experiments align with India's Bio-E3 policy - Biotechnology for Economy, Environment, and Employment - approved by the Cabinet and championed by Prime Minister Narendra Modi. Dr Gokhale highlighted that DBT's collaboration with ISRO is part of a long-term roadmap extending to 2040. The insights gained from these studies could revolutionise bio-manufacturing, especially in areas like carbon dioxide fixation and metabolic engineering. For example, algae used in space could be adapted to trap industrial emissions on Earth, offering sustainable solutions to climate challenges. A Vision For Viksit Bharat Dr Gokhale emphasised the transformative potential of cross-disciplinary science. From sports medicine to space biology, DBT is expanding its horizons to contribute to Viksit Bharat - a developed India. The department's pioneering role in biotechnology, from GM mustard to COVID vaccines, now extends to the final frontier, space. As India steps into the realm of space biology, these "baby steps" could soon become giant leaps, shaping the future of human health, sustainability, and innovation both in orbit and on Earth. India has big ambitions in space, from launching an Indian to space in 2027, having a space station by 2035 and landing an Indian on the moon by 2040. Group Captain Shukla has in fact laid the first firm footsteps for India's ambitious human space flight mission.
The Hindu
a day ago
- The Hindu
Collagen may worsen Type 2 diabetes, IIT-Bombay study finds
Researchers from IIT Bombay have found that collagen I -- a structural protein commonly found in the body --may worsen Type 2 diabetes by helping harmful clumps of a hormone called amylin form in the pancreas. This discovery adds a new layer to our understanding of how the disease progresses and why some treatments may fall short. In Type 2 diabetes, the pancreas produces both insulin and amylin. While insulin helps control blood sugar, excess amylin can misfold and form sticky clumps that damage the insulin-producing β-cells. The study found that in diabetic tissue, collagen I acts like a scaffold that speeds up amylin clumping, making it more toxic and harder for the body to clear. The team used advanced lab techniques -- including surface plasmon resonance (to measure how tightly amylin sticks to collagen), atomic force microscopy (to study the force between molecules), thioflavin T fluorescence (to track clump formation), and NMR spectroscopy (to identify interacting regions) -- to show how collagen I accelerates amylin aggregation. Computer simulations and studies on diabetic mice and human tissue further confirmed the link. Tests on lab-grown β-cells showed that when amylin and collagen were both present, the cells experienced more stress, higher death rates, and reduced insulin output. The researchers say this highlights the importance of the environment around cells, not just what happens inside them. Targeting the interaction between amylin and collagen could lead to more effective treatments. The team is now developing models using cryo-electron microscopy and exploring ways to support pancreas repair using 3D scaffolds. The study was funded by the Wadhwani Research Centre for Bioengineering, IIT Bombay and national research bodies including the Department of Biotechnology.
